Product Information
ETHOSUXIMIDE 250 MG/5 ML SOLN is a generic product labeled by PAI Holdings LLC, priced at $0.0893 per ML under NDC 00121067016. Its NADAC has been published 611 times since Aug 27, 2014.
The Low Outlier badge above means this manufacturer's average price in the ETHOSUXIMIDE market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 mg/5mL
Manufacturer
PAI Holdings LLCNDC
00121067016
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ETHOSUXIMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040253On Market Since
11/22/2000
Pharmacological Classes
Price Statistics
The NADAC for ETHOSUXIMIDE 250 MG/5 ML SOLN has been published 611 times since Aug 27, 2014, and over the history we have for it it has declined 61.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0893 per ML |
|---|---|
| All-time high | $0.3226 (Feb 11, 2015) |
| All-time low | $0.0626 (Jul 20, 2022) |
| 52-week high | $0.0965 |
| 52-week low | $0.0893 |
| Median price | $0.1938 |
| Average price | $0.1814 |
| Largest weekly change | +46.5% (Aug 22, 2018) |
| Weeks tracked | 611 |
| Tracking since | Aug 27, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ETHOSUXIMIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ETHOSUXIMIDE 250 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for ETHOSUXIMIDE 250 MG/5 ML SOLN, manufactured by PAI Holdings LLC, is $0.0893 per ML (NDC 00121067016), effective Jun 24, 2026.
How has the price of ETHOSUXIMIDE 250 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for ETHOSUXIMIDE 250 MG/5 ML SOLN has declined 61.2%. It has been tracked across 611 weekly CMS publications since Aug 27, 2014.
What are the highest and lowest recorded NADAC prices for ETHOSUXIMIDE 250 MG/5 ML SOLN?
Since Aug 27, 2014, the NADAC for ETHOSUXIMIDE 250 MG/5 ML SOLN has ranged from a low of $0.0626 (Jul 20, 2022) to a high of $0.3226 (Feb 11, 2015), with a median of $0.1938 per ML.
Are there cheaper alternatives to ETHOSUXIMIDE 250 MG/5 ML SOLN?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ETHOSUXIMIDE 250 MG/5 ML SOLN, so no direct lower-cost alternative is listed.
Who manufactures ETHOSUXIMIDE 250 MG/5 ML SOLN?
ETHOSUXIMIDE 250 MG/5 ML SOLN (NDC 00121067016) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification